CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

When should I use flow cytometry instead of western blot?

Read More
All Posts

Western blotting is used to detect proteins and analyze their expression using antibodies, but it does have its limitations. Flow cytometry also employs antibodies, but it uses fluorescence to detect and analyze protein expression on a cell-by-cell basis.

Flow cytometry enables quantitative analysis of protein expression, signaling states, and physical characteristics (cell size/granularity) at the single-cell level. Modern flow cytometers are capable of collecting data on multiple proteins from thousands of cells per second in a heterogeneous mixture. While flow cytometry is commonly employed to identify cell types using phenotypic markers expressed on the cell surface, it can also be used to measure intracellular signaling events.

Studying Cellular Signaling: Switching from WB to Flow Cytometry

Researchers pursuing hypotheses about signaling events traditionally start with western blot (WB). In this technique, lysates are pooled and analyzed one protein at a time, and infrequent signaling events may be missed due to insufficient detection sensitivity. Western blotting has limited capability to perform multiparameter quantitative analysis. Another drawback is that workflows can take a day or more to complete.

18-FLC-47212 fig 1

Flow cytometry is an ideal solution to avoid these shortcomings, enabling multiplexed and quantitative analysis of signaling events with greater sensitivity and precision than western blot, in just a few hours. Importantly, by collecting discrete data points from individual cells, flow cytometry enables researchers to identify and quantify subpopulations of cells that exhibit specific signaling responses, to explore the range of responses in those cells, and to correlate multiple quantitative readouts. In short, signaling flow cytometry enables you to ask new research questions and characterize important signaling events from the plasma membrane to the nucleus.

Advantage for Analyzing Signaling Events

Flow Cytometry

Western Blot

Study single cell analysis Yes No
Ability to detect infrequent or rare signaling events High Low
Identification of subpopulations in with which signaling changes occur Yes, simultaneous Only following cell population separation/ enrichment steps
Multiparameter analysis Yes No
Throughput  High Low
Assay duration (sample prep through analysis) 2-4 hours 1-2 days depending on length of primary antibody incubation
Signaling quantification Yes, simultaneous Varies by set-up:
- Traditional film method, no
- Digital imager, yes

 

This video describes four situations where it can be worth using flow cytometry instead of western blot:

Video: 4 Situations Where Flow Cytometry Might Be More Useful Than Western Blotting

Get Started with Flow

CST offers a diverse selection of antibodies and reagents for flow cytometry, supporting both quantitative analysis of intracellular signaling pathways and phenotyping. Our expertise in antibody design, conjugation, and flow cytometry enables us to develop and validate antibodies that you can use in your flow cytometry experiments with confidence. And the same scientists who develop and validate our flow cytometry products also provide technical support to ensure your experiments are successful.

 

 

Cell Signaling Technology
Cell Signaling Technology
Cell Signaling Technology (CST) is a different kind of life science company—one founded, owned, and run by active research scientists, with the highest standards of product and service quality, technological innovation, and scientific rigor. CST is a company of caring people driven by a devotion to facilitating good science—a company committed to doing the right thing for our customers, our communities, and our planet.

Recent Posts

Mapping RNA-Protein Interactions with RBP-eCLIP: Powering Discovery in RNA Biology

Guest author Dr Vince Harjono is an Application Scientist Manager at Eclipsebio. CST and Eclipsebio have ...

Key Epithelial-Mesenchymal Transition (EMT) Markers in Cancer

EMT, or epithelial-mesenchymal transition, is a biological process in which epithelial cells gain the abi...
Susan Keezer, PhD Jun 4, 2025

Targeting the Tumor Microenvironment: Key Markers of the ECM

In recent years, cancer researchers have started paying closer attention to the extracellular matrix (ECM...
Susan Keezer, PhD May 28, 2025